# Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

> **NCT00085163** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** celecoxib
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00085163
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-11
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00085163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00085163, "Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00085163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*